Zoono USA is seeking to change the conversation about how we deal with germs in this country by raising awareness of this innovative technology and by demonstrating product effectiveness across the broadest range of environments, from hospitals and facilities that treat humans to veterinary and animal settings to agriculture and manufacturing.

Zoono Group Limited is a privately-owned company based in New Zealand that specializes in the development, manufacture and global distribution of a suite of unique, proven, long-lasting and environmentally-friendly antimicrobial solutions.

Over the past 5 years, Zoono has developed many unique products (together with specific industry application protocols) that enable our customer’s partners and distributors to realize and maximize revenue-producing and commercial opportunities for these products and services.

Zoono Group has also developed (and owns) a wealth of intellectual property based around the “Zoono Molecule” – a unique, antimicrobial that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mold. Best of all, it has proven efficacy and longevity, it does not leach and cannot diminish in strength.

Today, Zoono Group has established a global network of customers and distributors that is spread across 42 countries and territories. As the market leader in its field, Zoono Group continues to develop new products and industry applications via a strong base of scientific, technical and training support.